Dr. Barry B. Bercu 1944-2023 Barry B. Bercu, M.D. died on Friday, November 24, 2023. Dr. Bercu, a pediatric endocrinologist…
Read MoreMore Articles
Medication Shortage Alert – Pamidronate Disodium Injection: Anna Ryabets-Lienhard, DO, Drugs and Therapeutics Committee Update 10/25/23: As of August-September, there has been a national shortage of pamidronate IV injection. The…
Read MoreNovo Nordisk announced on 11/8/2023 that their long-acting insulin, Levemir®, will be phased out from United States markers completely discontinuing by December 2024. It cited manufacturing constraints, reduced patient access and…
Read MoreJade Wyatt, MD I am currently a third-year pediatric endocrinology fellow at the University of North Carolina. I grew up in Texas, attended medical school at the University of Oklahoma,…
Read MoreThe Somatomedin and Dual Effector Theories of Growth Hormone Action Submitted by Alan D. Rogol, M.D., Ph.D. The somatomedin hypothesis stated that the uptake of sulfate in, for example rat…
Read MoreNew Drugs and Therapeutics Update – NGENLA By Dania Al-Hamad, MD, and Christine Yu, MD NGENLA (somatrogon-ghla), a once-weekly, human growth hormone analog, was approved by the FDA in…
Read MoreHistorical Tidbit: Robert T. Morris (1857-1945) and Human Ovarian Transplantation Submitted by Alan D. Rogol, M.D., Ph.D. Robert Morris was an exceptional surgeon in New York City. He was among…
Read MorePatricia Chu, MD I am a fourth-year Combined Adult and Pediatric Endocrinology Fellow at Penn Medicine/Children’s Hospital of Philadelphia and am currently in the Master of Science in Clinical Epidemiology (MSCE)…
Read MoreBrief Therapeutic Update from PES Drugs and Therapeutics Committee Jardiance® (empagliflozin) and Synjardy® (empagliflozin and metformin hydrochlorothiazide) Jardiance® (empagliflozin) and Synjardy® (empagliflozin and metformin hydrochlorothiazide) were approved by the…
Read More